PACS CEO Jason Hulse Murray Sells $3.3M of Stock

On October 23, 2026, Jason Hulse Murray, Co-Founder, CEO, and Chairman of PACS Group, Inc. (NYSE: PACS), sold 68,917 shares for about $3,349,173. The sale was reported on a Form 4 filing with the SEC. The average sale price was $48.60 per share, while the stock closed at $47.64 that day.

PACS PACS Group, Inc.

$47.64 ▲ +20.58% year to date

1M 3M YTD

Daily close · Oct 23, 2026

Inside Jason Hulse Murray's Trade

This sale reduced Murray's stake in PACS Group by 0.13%, leaving him with approximately 54,188,200 shares. The transaction was part of a planned selling strategy, as indicated by the filing.

Other Institutional Activity in PACS

Cohen & Steers Inc. reduced its holdings by 780,054 shares, ending with 8,343,381 shares worth about $406.8 million. Crewe Advisors LLC increased its stake by 553,034 shares, bringing its total to 3,307,188 shares valued at approximately $161.3 million. American Century Companies Inc. also raised its position, adding 1,298,580 shares for a total of 3,108,196 shares valued at about $151.6 million. Ameriprise Financial, Inc. grew its holdings by 873,697 shares, totaling 1,995,116 shares worth around $97.3 million. In contrast, Alyeska Investment Group, L.P. cut its stake by 1,463,403 shares, leaving it with 1,539,065 shares valued at about $75.0 million.

PACS Group, Inc. Stock Up 2.7%

PACS Group recently traded around $48.76, which is above its 50-day moving average of $43.73 and its 200-day average of $39.53. The stock is just below its 52-week high of $49.49, but significantly above its low of $10.31.

Recent Earnings

PACS Group reported trailing twelve-month revenue of about $5.55 billion and an EPS of $1.71. The next earnings report is expected on November 9, 2026.

Insider Buying and Selling at PACS Group, Inc.

In addition to this recent sale, Jason Hulse Murray has been active in selling shares over the past week. On October 21, he sold 6,610 shares for about $314,755. Earlier, he sold 37,477 shares for roughly $1.8 million on October 20, and 1,620 shares for about $77,060 on October 19. These transactions were all planned.

Analysts Set New Price Targets

On August 6, 2026, UBS maintained a "Buy" rating with a price target of $60.00, while RBC Capital also kept its "Outperform" rating with a target of $57.00. Truist Securities maintained a "Buy" rating with a target of $62.00. Oppenheimer and JP Morgan also upheld their ratings, with targets of $57.00 and $58.00, respectively. The average target price among analysts is $59.00, reflecting a strong buy recommendation with six opinions.

About PACS Group, Inc.

PACS Group, Inc. operates skilled nursing and assisted living facilities across the United States. Founded in 2013 and based in Salt Lake City, Utah, the company focuses on providing senior care and independent living options. The recent insider sales may reflect strategic financial planning as the company continues to expand its operations.

Bottom Line

Investors should keep an eye on PACS Group's upcoming earnings report on November 9, 2026, for insights into the company's performance. Additionally, watch for further insider transactions and institutional activity as the market responds to these developments.